Cymbaluk-Płoska, A., Gargulińska, P., Bulsa, M., Kwiatkowski, S., Chudecka-Głaz, A., & Michalczyk, K. (2021). Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer? MDPI AG.
Chicago Style (17th ed.) CitationCymbaluk-Płoska, Aneta, Paula Gargulińska, Michał Bulsa, Sebastian Kwiatkowski, Anita Chudecka-Głaz, and Kaja Michalczyk. Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer? MDPI AG, 2021.
MLA (8th ed.) CitationCymbaluk-Płoska, Aneta, et al. Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer? MDPI AG, 2021.
Warning: These citations may not always be 100% accurate.